Gentiva Health Services Location: 3150 North Elm Street Suite 102, Greensboro, North Carolina 27408 Ratings: Phone: (336) 288-1181 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Brookdale Home Health Winston Location: 7900 Triad Center Drive, Suite 250, Greensboro, North Carolina 27409 Ratings: Phone: (336) 668-4558 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Hospice And Palliative Care Of Greensboro Location: 2500 Summit Avenue, Greensboro, North Carolina 27405 Ratings:NA Phone: (336) 621-2500 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Encompass Home Health Of North Carolina Location: 5 Oak Branch Drive, Ste 5e, Greensboro, North Carolina 27407 Ratings: Phone: (336) 274-6937 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Bayada Home Health Care, Inc Location: 1500 Pinecroft Road, Suite 119, Greensboro, North Carolina 27407 Ratings: Phone: (336) 884-8869 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Interim Healthcare Of The Tria Location: 2100-t West Cornwallis Drive, Greensboro, North Carolina 27408 Ratings: Phone: (336) 273-4600 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Liberty Home Care Location: 1306 W Wendover Avenue Suite 100, Greensboro, North Carolina 27408 Ratings:NA Phone: (910) 815-3122 Health Services: Nursing Care, Physical Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
News Archive
Intellectual disabilities are often caused by a mutation that damages a gene, preventing the associated protein from functioning properly.
Aerie Pharmaceuticals, a biotechnology company focused on the discovery and development of novel treatments for glaucoma, today announced positive results from a Phase 2a study of its Rho-kinase (ROCK) inhibitor, AR-12286. The study evaluated the safety, tolerability and efficacy of three different doses of AR-12286 in 88 patients with primary open angle glaucoma or ocular hypertension.
Writing in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Gary Darmstadt, head of the family health division at the foundation, and Monica Kerrigan, a family planning expert, introduce the blog's new series, "What's Your Method?," which "offers a window into many of the contraceptive options for women and girls around the world."
A new study by US-based researchers shows the presence of protective antibodies that target the N-terminal domain (NTD) of the spike instead of the spike receptor-binding domain (RBD).
› Verified 8 days ago